Many European cigarette brands can be unknown to U.S. smokers since they are not manufactured in the USA. But that doesn’t mean they are not worth trying, especially as they can now be bought from online cigarette stores. So here is a list of Europe’s top selling cigarette brands.

Super Premium segment

Kent is the best selling brand made by British American Tobacco. Kent is available in more than 60 countries across the planet, and enjoys leading positions in most markets across Europe. The brand offers innovative products, including the Kent Nanotek line and Kent Convertibles, equipped with menthol flavored capsules.

Parliament a luxury cigarette brand manufactured by Philip Morris International. Parliament was introduced to fit the needs of rich adult smokers, who wanted to pay more for a product with outstanding quality. The cigarettes of this brand come with high tech recessed filters that cool the smoke, helping to making it less dangerous. The brand offers several styles, varying in size and strength.

Davidoff is a legendary cigarette brand, currently owned by Imperial Tobacco Company. One of the oldest brands in cigarette industry, Davidoff delivers a magnificent combination of superb quality and bracing smoke. The brand family includes 9 styles, from king size to slims and compact size cigarettes.

Premium and mid cost segment

Marlboro the most popular tobacco product ever, Marlboro needs no advertisement. Yet, should only be mentioned here that the product range of European Marlboros differs to that of U.S. one, however it still offers many remarkable products.

Winston is the second top selling brand across the world including Europe, where it even performs better than Marlboro in several markets, including Ukraine. In addition, Winston manufacturer, Japan Tobacco International, launches new styles and pack designs regularly to keep up to the expectations of European customers.

Camel is the iconic cigarette brand, famous across the world, including Europe and probably one of the most recognized tobacco products for Japan Tobacco International, the maker of this brand across the world excluding USA. The brand is selling in several regular and menthol styles in European countries.

Low end segment

Bond Street is a low cost brand manufactured by PMI. The best features of Bond Street include great quality, peculiar to all Philip Morris products, wide assortment of versions and of course, affordable price. In addition, Bond is probably the only low cost product to be offered in ultra low tar category of cigarettes with 0.1mg of nicotine.

Red & White the second low cost product offered by Philip Morris International, which has already been named the major growth brand for the company. Moderate price and high quality, as well as broad product range contribute to the growing popularity of Red & White brand across Europe.

Hilton, manufactured by British American Tobacco is the company’s leading brand in this category. Currently it is offered in two king size styles and two super slim ones.

Science ‘wrong’ in eu’s proposed e-cigarette law – health – 23 january 2014 – new scientist

Cigarettes online Blog Archive Buy more cigarettes online – tax free price

Fifteen prominent scientists who have investigated the health consequences of electronic cigarettes have accused European Union regulators of misinterpreting their results. The scientists say the EU aim is to draft an unjustifiably burdensome new law to regulate e cigarettes.

Their argument is made in a letter to the EU’s health commissioner Tonio Borg. The scientists state that if the newly amended Tobacco Products Directive becomes law as it stands which could happen as soon as April it will severely limit the scope for smokers of real cigarettes to give up or cut down by switching to e cigarettes, which contain nicotine but not the tobacco that contains tar and thousands of other substances harmful to health.

“If wisely regulated, e cigarettes have the potential to make cigarettes obsolete and save millions of lives worldwide,” the signatories say in the letter, which was also sent to members of the European Parliament, European Commission and the Council of Ministers the three bodies that will decide the fate of the directive. “Excessive regulation, on the contrary, will perpetuate the existing levels of smoking related disease, death and health care costs,” it continues, pointing out that smoking currently kills 700,000 Europeans each year.

The British Medical Association told New Scientist that longer trials are needed to learn more about the long term effects of e cigarettes. “Better regulation of e cigarettes is essential,” a spokesperson says. “Studies have shown that they are unreliable in the levels of nicotine they provide and there’s a lack of evidence regarding their safety.”

var ord ( () 10e12) (‘

Ethical imperative

The signatories of the letter say regulation must be built on robust science. The cited errors relate to the strength of nicotine solutions allowed, the doses needed to match the nicotine “hit” from real cigarettes, an overstatement of the known dangers from nicotine and unwarranted assumptions that e cigarettes will become “gateway products”, tempting non smokers and young people to try real cigarettes.

As it stands, say the scientists, the draft would unnecessarily restrict nicotine content in the liquids that are vapourised in e cigarettes to deliver the drug to users when they suck on the devices.

Currently, the draft would restrict content to 20 milligrams of nicotine per millilitre of fluid, on the grounds that this matches the dose from a real cigarette over the same period of smoking. An estimated 20 to 30 per cent of e cigarette users prefer higher doses than this, and so could potentially return to smoking real cigarettes unless stronger e cigarettes are allowed, warn the researchers.

Outdated, overestimated

One of the signatories, Konstantinos Farsalinos of the University Hospital in Gasthuisberg in Leuven, Belgium, says his own research on e cigarettes was used to reach this figure, but that it has been misinterpreted. His work shows that 20 milligrams is less than half of what is required to match the output from a real cigarette, equivalent to roughly 50 milligrams per millilitre.

Much of the misinterpretation of results comes from outdated information and overestimation of the toxicity of nicotine, say the researchers.

The EU’s current assumption that 60 milligrams of nicotine is lethal is incorrect, they say, and dates from self experiments reported in a pharmacology textbook published in 1856. “This is not the case, and people have ingested doses 60 times higher, which only led to nausea and vomiting,” says the scientists’ letter. “Poisoning from tobacco, nicotine replacement medications or e cigarette liquid is extremely rare, and there is no risk of overdosing through inhalation,” they say.

Deep breath

Another gripe with the current draft of the Tobacco Products Directive is its insistence that electronic cigarettes deliver nicotine doses “consistently”. This is nonsensical, they say, because “vapers” the users of e cigarettes dictate for themselves how much nicotine they breathe in.

Research shows, for example, that individual users of the same electronic cigarette differ in nicotine intake by as much as 20 fold because they inhale different amounts at different rates.

The scientists also take issue with wording in the directive implying that there is strong evidence that e cigarettes lead to nicotine addiction and in turn the smoking of real cigarettes. “Existing data do not suggest that electronic cigarettes are having any such effects,” they go on to say that the evidence suggests the use of e cigarettes helps smokers of all ages reduce or give up smoking.

Dog’s breakfast

Supporters of e cigarettes argue that they could help smokers avoid disease and premature death. Proponents are lobbying either for further amendments to the draft directive to ease the restrictions, or for the e cigarettes component of the directive to be removed altogether and re drafted as an independent regulation.

“Otherwise, we’ll end up with a dog’s breakfast that will set the direction of e cigarette legislation for decades,” says Clive Bates, former director of UK public health charity Action on Smoking and Health (ASH), and a prominent campaigner for harm reduction through e cigarettes.

But time to amend the directive is limited because it will be read in the European Parliament in March. If passed, it could be rubber stamped into law by the Council of Ministers a month later.

The EU’s Environment, Public Health and Food Safety committee met 22 January in Brussels, Belgium, to consider the latest draft.

“My main issue with the directive is that it is unbalanced in its treatment of e cigarettes compared to tobacco products,” says signatory Chris Bullen of the University of Auckland in New Zealand. Last year Bullen headed a trial demonstrating that e cigarettes are at least as effective as nicotine patches in helping people quit smoking or cut down. “Proportionate regulation is what’s needed, sufficient to give consumers confidence in the quality, reliability and safety of e cigarettes,” he says.